Status:

COMPLETED

Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer

Lead Sponsor:

Ferring Pharmaceuticals

Conditions:

Prostate Cancer

Eligibility:

MALE

18+ years

Phase:

PHASE3

Brief Summary

The purpose of this phase 3B trial was to see how well a new trial drug (degarelix) works in terms of reducing the size of the prostate volume in prostate cancer patients who were scheduled to undergo...

Eligibility Criteria

Inclusion

  • Patient has given written informed consent before any trial-related activity is performed.
  • Has a confirmed prostate cancer in which this type of treatment is needed.

Exclusion

  • Previous treatment for prostate cancer
  • Previous trans-urethral resection of the prostate
  • Patients who are lymph node positive or have other metastatic disease
  • Use of urethral catheter
  • Current treatment with a 5-alpha reductase inhibitor or α-adrenoceptor antagonist.
  • History of severe untreated asthma, anaphylactic reactions, or severe urticaria and/or angioedema.
  • Hypersensitivity towards any component of the investigational product
  • Other previous cancers within the last five years with the exception of prostate cancer and some types of skin cancer.
  • Certain risk factors for abnormal heart rhythms/QT prolongation (corrected QT interval over 450 msec., Torsades de Pointes or use of certain medications with potential risk)
  • Clinical disorders other than prostate cancer including but not limited to renal, haematological, gastrointestinal, endocrine, cardiac, neurological, psychiatric disease, alcohol or drug abuse or other conditionals as judged by the investigator.

Key Trial Info

Start Date :

April 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2011

Estimated Enrollment :

246 Patients enrolled

Trial Details

Trial ID

NCT00833248

Start Date

April 1 2009

End Date

September 1 2011

Last Update

October 4 2012

Active Locations (66)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 17 (66 locations)

1

Alabama Research Center

Birmingham, Alabama, United States, 35209

2

Urology Centers of Alabama

Homewood, Alabama, United States, 35209

3

Alaska Urological Association

Anchorage, Alaska, United States, 99508

4

Arizona Urologic Specialists

Tuscon, Arizona, United States, 85712